Abstract
In this issue of Blood, Ettinger et al show that the T-cell response to therapeutic factor VIII (FVIII) in a patient with severe hemophilia A due to a multi-exon F8 deletion was oligoclonal and directed against a single epitope located in the C2 domain of the molecule. They further demonstrated that the HLA-DRB1∗01:01-restricted T-cell epitope was recognized by the T cells of 2 other hemophilia A patients with the A2201P missense mutation.1
Cite
CITATION STYLE
Lacroix-Desmazes, S., & Maillere, B. (2016, October 20). Monoepitopic anti-FVIII T-cell response. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2016-08-732123
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.